Download PDF
CC BY-NC-ND 4.0 · Journal of Social Health and Diabetes 2019; 7(02): 54-57
DOI: 10.1055/s-0039-3401980
Review Article

Diabetes and Addictive Disorders

Yatan Pal Singh Balhara
1   National Drug Dependence Treatment Center and Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi
,
Sarita Bajaj
2   Department of Medicine, Regional Institute of Medical Sciences, Imphal, India
,
Mangesh Tiwaskar
3   Shilpa Medical Research Center, Mumbai, Maharashtra, India
,
Ameya Joshi
4   Endocrine and Diabetes Clinic Mumbai, Bhaktivedanta Hospital And Research Institute, Thane, Maharashtra, India
,
Vaishali Deshmukh
5   Sassoon General Hospital and BMC, Pune, Maharashtra, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Prevalence of addictive disorders among persons with diabetes mellitus (DM) (type 1 and type 2) ranges from 9.6 to 29%. Excessive and problematic use of psychoactive substances in persons with diabetes results in poor glycemic control with frequent hyperglycemic crisis. Tobacco, alcohol, cannabis, benzodiazepines, inhalants, and stimulants are common psychoactive substances used among persons with diabetes in India. The daily use of alcohol by men and women with DM should not exceed 15 and 30 g of ethanol, respectively. Use of other psychoactive substances is not recommended for persons with DM. Various screening tools exist for assessing substance abuse like WHO-ASSIST, Alcohol Use Disorders Identification Test (AUDIT), Fagerström Test for Nicotine Dependence (FTND), and Opioid Risk Tool. Integrated management of co-occurring addictive disorder and DM is recommended. Psychosocial treatments for substances include brief interventions (BIs), motivational interviewing, contingency management, relapse prevention, and cognitive behavior therapy

Keywords

psychoactive substance abuse - screening tools - behavior therapy


Publication History

Article published online:
30 March 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Kumar A, Goel MK, Jain RB, Khanna P, Chaudhary V. India towards diabetes control: Key issues. Australas Med J 2013; 6 (10) 524-531
    CrossrefPubMedGoogle Scholar
  • 2 Nam Han Cho. et al. International Diabetes Federation. IDF Diabete s Atlas. 8th ed. 2017: 78-79
  • 3 Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27 (05) 1047-1053
    CrossrefPubMedGoogle Scholar
  • 4 United Nations Office on Drugs and Crime. World Drug Report 2017. Vol 1. Vienna: United Nations Office on Drugs and Crime; 2017: 36
    Google Scholar
  • 5 Gururaj G, Varghese M, Benegal V, et al. National Mental Health Survey of India, 2015–16: Summary. Bengaluru, National Institute of Mental Health and Neuro Sciences; 2016 [cited 2017 Dec 07]. 62p NIMHANS Publication No. 128, 2016
  • 6 Martínez-Aguayo A, Araneda JC, Fernandez D, Gleisner A, Perez V, Codner E. Tobacco, alcohol, and illicit drug use in adolescents with diabetes mellitus. Pediatr Diabetes 2007; 8 (05) 265-271
    CrossrefPubMedGoogle Scholar
  • 7 Wu L-T, Ghitza UE, Batch BC. et al. Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data. Drug Alcohol Depend 2015; 156: 162-169
    CrossrefPubMedGoogle Scholar
  • 8 Ng RSH, Darko DA, Hillson RM. Street drug use among young patients with Type 1 diabetes in the UK. Diabet Med 2004; 21 (03) 295-296
    CrossrefPubMedGoogle Scholar
  • 9 Humeniuk RE, Henry-Edwards S, Ali RL, Poznyak V, Monteiro M. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Manual For Use In Primary Care. Geneva: World Health Organization; 2010
    Google Scholar
  • 10 Saunders JB, Aasland OG, Babor TF. de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction 1993; 88 (06) 791-804
    CrossrefPubMedGoogle Scholar
  • 11 Fagerstrom K-O, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 1989; 12 (02) 159-182
    CrossrefPubMedGoogle Scholar
  • 12 Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med 2005; 6 (06) 432-442
    CrossrefPubMedGoogle Scholar
  • 13 World Health Organization. ICD-10: International statistical classification of diseases and health-related problems. Geneva: World Health Organization 1992
  • 14 American Psychiatric Association, DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association 2013
  • 15 Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008; 165 (02) 179-187
    CrossrefPubMedGoogle Scholar
  • 16 Kaner EFS, Dickinson HO, Beyer FR. et al. Effectiveness of brief alcohol interventions in primary care populations. In: Kaner EFS. ed. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2007: p. CD004148
    Google Scholar
  • 17 Vasilaki EI, Hosier SG, Cox WM. The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review. Alcohol Alcohol 2006; 41 (03) 328-335
    CrossrefPubMedGoogle Scholar
  • 18 Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006; 101 (11) 1546-1560
    CrossrefPubMedGoogle Scholar
  • 19 Irvin JE, Bowers CA, Dunn ME, Wang MC. Efficacy of relapse prevention: a meta-analytic review. J Consult Clin Psychol 1999; 67 (04) 563-570
    CrossrefPubMedGoogle Scholar
  • 20 Windsor LC, Jemal A, Alessi EJ. Cognitive behavioral therapy: a meta-analysis of race and substance use outcomes. Cultur Divers Ethnic Minor Psychol 2015; 21 (02) 300-313
    CrossrefPubMedGoogle Scholar
  • 21 Wang D, Wang Y, Wang Y, Li R, Zhou C. Impact of physical exercise on substance use disorders: a meta-analysis. PLoS One 2014; 9 (10) e110728
    CrossrefPubMedGoogle Scholar
  • 22 Harvey JN. Psychosocial interventions for the diabetic patient. Diabetes Metab Syndr Obes 2015; 8: 29-43
    PubMedGoogle Scholar
  • 23 Stead LF, Perera R, Bullen C. et al. Nicotine replacement therapy for smoking cessation. In: Stead LF. ed. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2012: p. CD000146
    Google Scholar
  • 24 Sweeney CT, Fant RV, Fagerstrom KO, McGovern JF, Henningfield JE. Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability. CNS Drugs 2001; 15 (06) 453-467
    CrossrefPubMedGoogle Scholar
  • 25 Mills EJ, Wu P, Lockhart I, Thorlund K, Puhan M, Ebbert JO. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis. Ann Med 2012; 44 (06) 588-597
    CrossrefPubMedGoogle Scholar
  • 26 Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. In: Hughes JR. ed. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2007: p. CD000031
    Google Scholar
  • 27 Kaur K, Kaushal S, Chopra SC. Varenicline for smoking cessation: A review of the literature. Curr Ther Res Clin Exp 2009; 70 (01) 35-54
    CrossrefPubMedGoogle Scholar
  • 28 Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation. In: Hartmann-Boyce J. ed. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2016. p. CD010216
    Google Scholar
  • 29 Galanter M, Kleber HD, Brady K. The American Psychiatric Publishing Textbook Of Substance Abuse Treatment. . American Psychiatric Pub. 2014
    Google Scholar
  • 30 Palatty PL, Saldanha E. Status of disulfiram in present day alcoholic deaddiction therapy. Indian J Psychiatry 2011; 53 (01) 25-29
    CrossrefPubMedGoogle Scholar
  • 31 De Sousa A. The pharmacotherapy of alcohol dependence: a state of the art review. Mens Sana Monogr 2010; 8 (01) 69-82
    CrossrefPubMedGoogle Scholar
  • 32 Kleber HD. Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues Clin Neurosci 2007; 9 (04) 455-470
    CrossrefPubMedGoogle Scholar
  • 33 Mattick RP, Breen C, Kimber J, Davoli M.. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. In: Mattick RP. ed. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2014: p. CD002207
    Google Scholar
  • 34 Johansson BA, Berglund M, Lindgren A. Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review. Addiction 2006; 101 (04) 491-503
    CrossrefPubMedGoogle Scholar
  • 35 Nagrebetsky A, Brettell R, Roberts N, Farmer A. Smoking cessation in adults with diabetes: a systematic review and meta-analysis of data from randomised controlled trials. BMJ Open 2014; 4 (03) e004107
    CrossrefPubMedGoogle Scholar
  • 36 Handelsman Y, Mechanick JI, Blonde L. et al; AACE Task Force for Developing a Diabetes Comprehensive Care Plan. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary. Endocr Pract 2011; 17 (02) 287-302
    CrossrefPubMedGoogle Scholar
  • 37 Qin R, Chen T, Lou Q, Yu D. Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes: meta-analysis of observational prospective studies. Int J Cardiol 2013; 167 (02) 342-350
    CrossrefPubMedGoogle Scholar
  • 38 Clair C, Cohen MJ, Eichler F, Selby KJ, Rigotti NA. The effect of cigarette smoking on diabetic peripheral neuropathy: a systematic review and metaanalysis. J Gen Intern Med 2015; 30 (08) 1193-1203
    CrossrefPubMedGoogle Scholar
  • 39 Baliunas DO, Taylor BJ, Irving H. et al. Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care 2009; 32 (11) 2123-2132
    CrossrefPubMedGoogle Scholar
  • 40 Hogendorf AM, Fendler W, Sieroslawski J. et al. Breaking the taboo: illicit drug use among adolescents with Type 1 diabetes mellitus. J Diabetes Res 2015; 00
    Google Scholar
  • 41 Haire-Joshu D, Heady S, Thomas L, Schechtman K, Fisher Jr EB. Depressive symptomatology and smoking among persons with diabetes. Res Nurs Health 1994; 17 (04) 273-282
    CrossrefPubMedGoogle Scholar
  • 42 Ahmed AT, Karter AJ, Liu J. Alcohol consumption is inversely associated with adherence to diabetes self-care behaviours. Diabet Med 2006; 23 (07) 795-802
    CrossrefPubMedGoogle Scholar